Prognostic marker analysis in pediatric posterior fossa ependymomas.
Journal Article (Journal Article)
NELL2 expression has been shown to identify patients with posterior fossa ependymomas (PFEp) that exhibit prolonged survivals. We analyzed expression NELL2; KI-67; Tenascin C; CD34; VEGF; and CA IX as well as vascular density against post-operative survival (Progression Free and Overall Survival; PFS, OS) in 31 patients under the age of 22 years.
Full Text
Duke Authors
Cited Authors
- McLendon, RE; Lipp, E; Gururangan, S; Fuchs, H; Zagzag, D; Herndon, J; Healy, P
Published Date
- July 2014
Published In
Volume / Issue
- 16 Suppl 3 /
Start / End Page
- iii27 -
PubMed ID
- 25165266
Pubmed Central ID
- PMC4144561
Electronic International Standard Serial Number (EISSN)
- 1523-5866
Digital Object Identifier (DOI)
- 10.1093/neuonc/nou208.17
Language
- eng
Conference Location
- England